Clinical trial
Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia
NCT00099996 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00099996 |
|---|---|
| Title | Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia |
| Official title | A Study to Assess Adding Ezetimibe 30 mg to Ongoing Treatment With Ezetimibe 10 mg in Patients With Homozygous Sitosterolemia |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Diseases, Metabolism, Inborn Errors |
| Intervention type | Drug |
| Interventions | SCH-58235, Ezetimibe |
| Enrollment | 3 |
| Start date | Dec 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Dec 22, 2004 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: